FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


15270 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
biverkning av natriumklodronat Adverse reaction to clodronic acid
natriumklodronatallergi Allergy to clodronic acid (finding)
natriumkromoglikat 2 %, ögondroppar Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye solution (clinical drug)
natriumkromoglykat 2 %, ögondroppar utan konserveringsmedel Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye solution (clinical drug)
natriumkromoglikat 20 mg, inhalationskapsel Sodium cromoglicate 20 mg/actuation powder for inhalation
natriumkromoglikat 20 mg/2 ml, för nebulisator Sodium cromoglicate 10 mg/mL solution for inhalation
natriumkromoglikat 5 mg, inhalator + spacer Sodium cromoglicate 5 mg/actuation powder for inhalation
biverkning av natriumkromoglikat Adverse reaction to cromoglicic acid
natriumkromoglikatallergi Allergy to cromoglicic acid (finding)
Sodium diatrizoate 25% infusion Amidotrizoic acid-containing product in parenteral dose form
natriumdiatrizoat 25 % infusionsvätska, lösning, flaska Amidotrizoic acid-containing product in parenteral dose form
Sodium diatrizoate 25% injection Amidotrizoic acid-containing product in parenteral dose form
natriumdiatrizoat 25 % injektionsvätska, lösning, ampull Amidotrizoic acid-containing product in parenteral dose form
Sodium diatrizoate 45% injection Amidotrizoic acid-containing product in parenteral dose form
natriumdiatrizoat 45 % injektionsvätska, lösning, ampull Amidotrizoic acid-containing product in parenteral dose form
Sodium diatrizoate powder BP Product containing amidotrizoic acid (medicinal product)
natrium-järn(III)glukonatkomplex 12,5 mg/ml, injektionsvätska, lösning, ampull Product containing precisely ferric ion (as sodium ferric gluconate complex) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug)
natriumfluorid 0,2 % Product containing only sodium fluoride (medicinal product)
Sodium fluoride 1.1% Product containing only sodium fluoride (medicinal product)
natriumfluorid 1,1 %, kräm Fluoride ion (as sodium fluoride) 11 mg/g dental paste
natriumfluorid 1,1 %, gel Fluoride ion (as sodium fluoride) 11 mg/g dental paste
natriumfluorid 1,1 %, pasta Fluoride ion (as sodium fluoride) 11 mg/g dental paste
natriumfluorid 1,1 mg/ml Product containing only sodium fluoride (medicinal product)
natriumfluorid 1,23 %, pasta Fluoride ion (as sodium fluoride) 12.3 mg/g dental paste
natriumfluorid 2 % Product containing only sodium fluoride (medicinal product)
natriumfluorid 2 %, munhålelösning Product containing only sodium fluoride in oromucosal dose form (medicinal product form)
natriumfluorid 2 %, sköljvätska Product containing only sodium fluoride in oromucosal dose form (medicinal product form)
natriumfluorid 2 %, lösning Product containing only sodium fluoride (medicinal product)
natriumfluorid 2,21 mg, sugtablett Product containing precisely fluoride ion (as sodium fluoride) 2.21 milligram/1 each conventional release oromucosal lozenge (clinical drug)
natriumfluorid 2,2 mg, sugtablett Product containing precisely fluoride ion (as sodium fluoride) 2.21 milligram/1 each conventional release oromucosal lozenge (clinical drug)
natriumfluorid 2,50 mg/ml, lösning Product containing only sodium fluoride (medicinal product)
natriumfluorid 2,72 %, pasta Fluoride ion (as sodium fluoride) 27.2 mg/g dental paste
natriumfluorid 2,73 %, pasta Product containing only sodium fluoride (medicinal product)
natriumfluorid 2,9 %, pasta Product containing precisely fluoride ion (as sodium fluoride) 29 milligram/1 gram conventional release toothpaste (clinical drug)
natriumfluoridallergi Allergy to fluoride
biverkning av natriumfusidat Fusidic acid adverse reaction
överdos av natriumfusidat Fusidic acid overdose
överdos av natriumfusidat, med oklar avsikt Fusidic acid overdose
natriumhyaluronat 10 mg/ml, injektionsvätska, lösning, förfylld spruta 0,85 ml Sodium hyaluronate 10 mg/mL solution for injection
natriumhyaluronat 10 mg/ml, injektionsvätska för intraokulärt bruk, förfylld spruta 0,55 ml Sodium hyaluronate 10 mg/mL solution for injection
natriumhypoklorit 10 mikrogram/ml, ögondroppar Product containing only hyaluronic acid in ocular dose form (medicinal product form)
natriumhyaluronat 10 mikrogram/ml, ögondroppar utan konserveringsmedel Product containing only hyaluronic acid in ocular dose form (medicinal product form)
natriumhyaluronat 15 mg/ml, injektionsvätska, lösning, förfylld spruta Hyaluronic acid only product in parenteral dose form
natriumhyaluronat 23 mg/ml, injektionsvätska, lösning, förfylld spruta Product containing precisely sodium hyaluronate 23 milligram/1 milliliter conventional release solution for injection (clinical drug)
biverkning av natriumhyaluronat Adverse reaction to hyaluronic acid (disorder)
natriumhyaluronatallergi Allergy to hyaluronic acid
natriumhypoklorit 0,5 %, lösning Sodium hypochlorite only product
natriumhypoklorit 8 %, kutan lösning Product containing only sodium hypochlorite in cutaneous dose form (medicinal product form)
stark natriumkloritlösning 8 % Product containing only sodium hypochlorite in cutaneous dose form (medicinal product form)
natriumjododid (^131^I) 333 kBq-3,7 MBq, diagnostisk kapsel Sodium iodide (131-I) only product in oral dose form
Sodium iodide[131I] 37-7400MBq injection Sodium iodide (131-I) only product in parenteral dose form
natriumjodid (^131^I) 37-7 400 MBq, pulver för beredning av injektionsvätska, lösning, flaska Sodium iodide (131-I) only product in parenteral dose form
natriumjododid (^131^I) 37-7 400 MBq, behandlingskapsel Sodium iodide (131-I) only product in oral dose form
natriumjododid (^131^I) 37-5 550 MBq, behandlingskapsel Sodium iodide (131-I) only product in oral dose form
natriumjodid (^131^I) 740 MBq/ml, injektionsvätska Sodium iodide (131-I) only product in parenteral dose form
natriumjodhippurat (^123^I), injektionsvätska Product containing only iodohippurate (123-I) sodium in parenteral dose form (medicinal product form)
natriumjodhippurat (^131^I) 18,5 MBq/ml, injektionsvätska Product containing only iodohippurate (123-I) sodium in parenteral dose form (medicinal product form)
natriumjodhippurat (^131^I) 20 MBq/ml, injektionsvätska Product containing only iodohippurate (123-I) sodium in parenteral dose form (medicinal product form)
natriumjotalamat 54 %, injektionsvätska, lösning Iothalamic acid only product
natriumlaktat 0,16 mol per liter, infusionsvätska, lösning, påse Sodium lactate only product in parenteral dose form
natriumnitroprussid 25 mg/ml, injektionsvätska, lösning, ampull Product containing precisely sodium nitroprusside 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
biverkning av natriumnitroprussid Adverse reaction to nitroprusside
natriumnitroprussidallergi Allergy to nitroprusside (finding)
natriumperborat 68,6 %, munhålelösning Sodium perborate 686 mg/mL oromucosal solution for mouthwash
natriumperborat 68,6 %, munsköljvätska Sodium perborate 686 mg/mL oromucosal solution for mouthwash
natriumpikosulfat 10 mg per dospåse, oralt pulver Product containing precisely sodium picosulfate 66.7 microgram/1 milliliter conventional release oral solution (clinical drug)
natriumpolystyrensulfonat 100 %, pulver Polystyrene sulfonate only product
natriumpolystyrensulfonat 4,1 milliekvivalenter/g, pulver Polystyrene sulfonate only product
natriumpolystyrensulfonat 454 g pulver/flaska för suspenstion Polystyrene sulfonate only product
natriumstiboglukonat 100 mg/ml, injektionsvätska, lösning, flaska 100 ml Product containing precisely sodium stibogluconate 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
natriumtiosalicylat 50 mg/ml, injektionsvätska, lösning, ampull Product containing precisely sodium thiosalicylate 50 milligram/1 milliliter conventional release solution for injection (clinical drug)
natriumtiosulfatallergi Non-allergic hypersensitivity to sodium thiosulfate (finding)
natriumvalproat 100 mg, tablett Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug)
natriumvalproat 100 mg, krossbar tablett Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug)
fynd som rör TNM-stadieindelning tumör i mjukdelar American Joint Committee on Cancer allowable value
mjukvävnadsknöl i buken Soft tissue mass
mjukvävnadsknöl i huvudet Soft tissue mass
mjukvävnadsknöl i nedre extremitet Soft tissue mass
mjukvävnadsknöl i halsen Soft tissue mass
mjukvävnadsknöl i pelvis Soft tissue mass
mjukvävnadsknöl i torax Soft tissue mass
mjukvävnadsknöl i övre extremitet Soft tissue mass
Soft tissue repair Repair - action
Soft tissues of trunk Structure of soft tissues of trunk
Solid prosthetic ligament reconstruction Repair - action
solitär fibrös tumör, malign Solitary fibrous tumor and hemangiopericytoma grade 3 (morphologic abnormality)
plasmocytom Plasmacytoma
abdominal somatisk dysfunktion Somatic dysfunction of abdominal region (finding)
somatisk dysfunktion i knä Somatic dysfunction of knee region (finding)
somatisk orsak till impotens Erectile dysfunction due to psychophysiologic disorder (disorder)
Somatotropin inhibiting factor preparation Product containing somatostatin (medicinal product)
Somatropin 1.5mg powder Somatropin only product in parenteral dose form
somatropin 1,5 mg, pulver till injektionsvätska, lösning, flaska Somatropin only product in parenteral dose form
somatropin 1,5 mg, pulver till injektionsvätska, flaska + spädningsvätska Somatropin only product in parenteral dose form
somatropin 10 mg/flaska, lösning Somatropin 10 mg/mL solution for injection
Somatropin 5.8mg powder Somatropin only product in parenteral dose form
somatropin (rbe) 5,8 mg, pulver till injektionsvätska, lösning, flaska Somatropin only product in parenteral dose form
somatropin 5,8 mg, pulver till injektionsvätska, flaska + spädningsvätska Somatropin only product in parenteral dose form
somatropin och somatropinagonist Growth hormone receptor agonist
somatropin (epr) 10 mg/ml, injektionsvätska, lösning, cylinderampull 1,5 ml Somatropin only product in parenteral dose form
somatropin (epr) 3,33 mg/ml, injektionsvätska, lösning, cylinderampull 1,5 ml Somatropin only product in parenteral dose form

Start Previous Page 124 of 153 Next End


Reference Sets

Reference set descriptor

GB English

US English

Back to Start